ArticleBMC medical imaging2025
The value of radiomics features of white matter hyperintensities in diagnosing cognitive frailty: a study based on T2-FLAIR imaging.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhite matter hyperintensities (WMHs) are closely associated with cognitive frailty (CF). This study aims to explore the potential diagnostic value of WMHs for CF based on radiomics approaches, thereby providing a novel methodology for the early diagnosis and timely intervention of CF.
methodsThe present study conducted a retrospective analysis on 147 patients (77 with CF, 70 in the control group). Following an 8:2 ratio, the patients were randomly divided into training and testing sets. Repeated 5-fold cross-validation was adopted for model training and evaluation. Optimal radiomic features were extracted and selected from T2-FLAIR images, and multiple logistic regression analysis was utilized to identify independent risk factors. Three machine learning algorithms-K-Nearest Neighbors (KNN), Logistic Regression (LR), and Support Vector Machine (SVM)-were used to construct radiomic models, clinical models, and combined models. The performance of each model in diagnosing CF was evaluated using metrics including the area under the curve (AUC), area under the net benefit curve (AUNBC), and Brier score.
resultsIn the test set, the AUC values of KNN, LR, and SVM in the radiomics models were 0.860, 0.916, and 0.885, respectively; the AUC values of the clinical models were 0.868, 0.850, and 0.787, respectively; and the AUC values of the combined models were 0.906, 0.954, and 0.930, respectively. The decision curve analysis (DCA) demonstrated that the combined model was superior to the single models in terms of clinical decision-making efficacy.
conclusionThe radiomic model, clinical model, and combined model can effectively diagnose CF patients, with the combined model demonstrating the best diagnostic efficacy. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.